Don’t miss out our Satellite Symposium

Visit us at Booth #24

This year combines the World and Europe IUSTI congress into one and it is looking to be a very exciting and relevant event. The congress will be hosted in Trinity College Dublin, running under the theme of “The Appliance of Science” – emphasising the great practical advances that science has brought to our day-to-day clinical practice with patients, and to public health.

The programme will tackle newly emerging issues in the STI field, including:

• the rise of Syphilis and other STIs
• confronting Gonococcal Resistance
• addressing Sexual Health and Quality Sex in STI practice
• how STI practice can be improved through Programme Science

Mark your calendars for the SpeeDx Satellite Symposium and be sure to visit us at Booth #24 to talk about your Molecular Diagnostic needs.
 

Satellite Symposium

Diagnostics Defining Therapy – how resistance guided therapy is changing STI management

Thursday June 28^th, 2:30-3:45PM, Emmet Theatre

Learn about the latest in Gonorrhoea surveillance, M. genitalium macrolide resistance testing in Scotland and Barcelona and be part of an interesting panel discussion.

Symposium Chair: Jeff Klausner
 
Speakers:
A/Prof David Whiley – The University of Queensland Centre for Clinical Research, Brisbane Australia
Dr Kate Templeton – Royal Infirmary Edinburgh, UK
Dr Mateu Espasa Soley – Vall d’Hebron Institut de Recerca, Barcelona, Spain
 
Panel discussion:
A/Prof David Whiley, Dr Kate Templeton, Dr Elisa Mokany

Key Presentations at IUSTI Dublin

Presentation Title
Mycoplasma genitalium and fluoroquinolone resistance
Author
Jorgen Skov Jensen
Presented
Date: Thursday June 28^th
Atrium: Dining Hall @ 12:30 – 1:30PM

Symposium Title
Antimicrobial Resistance
Presentations
John White – Is Dual Therapy for Gonorrhea the Solution to the Threat of Antimicrobial Resistance?
Lisa Manhart – Resistance profiles and treatment outcomes among Mycoplasma genitalium (MG) infected men who have sex with men (MSM) with non-gonococcal urethritis (NGU)
Helen Fifer – The correlation between azithromycin minimum inhibitory concentration and clinical outcome for Gonorrhoea in the GTOG trial: does dual therapy treatment remain appropriate?
Presented
Date: Friday June 29^th
Edmund Burke Hall @ 11:15 – 12:30PM

Abstract Presentation Title
Gyrase a genotyping of Neisseria Gonorrhoeae for the rapid prediction of ciprofloxacin susceptibility: implementation, patient outcomes, and cost analysis
Author
Jeffrey Klausner
Presented
Date: Friday June 29^th
Hall: Beckett Room 1 @ 3:00 – 4:15PM